Suppr超能文献

口服控释药物的选择:医生的关键决策。

Selection of oral controlled-release drugs: a critical decision for the physician.

作者信息

Arnold R J, Kaniecki D J

机构信息

Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY.

出版信息

South Med J. 1993 Feb;86(2):208-14. doi: 10.1097/00007611-199302000-00013.

Abstract

Controlled-oral release dosage formulations of medications have become relatively prevalent in medicine today because of their ability to reduce noncompliance and, perhaps, to increase efficacy. However, there are many patient- and drug-related factors that may present special problems in product selection. For example, interchange of controlled-release brands that may have different absorption characteristics can result in therapeutic failure and/or toxicity. Especially in light of recent events associated with Food and Drug Administration product reviews, this paper outlines concepts that will assist physicians in making informed decisions regarding generic substitution of oral controlled-release products.

摘要

由于能够减少患者不依从性并可能提高疗效,药物的口服控释剂型如今在医学中已相对普遍。然而,有许多与患者和药物相关的因素可能在产品选择中带来特殊问题。例如,具有不同吸收特性的控释品牌之间的互换可能导致治疗失败和/或毒性。特别是鉴于近期与美国食品药品监督管理局产品审查相关的事件,本文概述了一些概念,这些概念将有助于医生在口服控释产品的仿制药替代方面做出明智的决策。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验